Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Barbara Yawn, MD
Researcher Adjunct Professor
Family and Community Health
University of Minnesota
Rochester, Minnesota, United States
Barbara P. Yawn, MD, MSc, FAAFP, is Adjunct Professor, Department of Family and Community Health at University of Minnesota. Dr. Yawn’s research interests include the diagnostic process, women’s health, and asthma identification and management.
Dr. Yawn received her undergraduate degree in Physics from Massachusetts Institute of Technology and proceeded to medical school at University of Missouri, Columbia where she joined Alpha Omega Alpha Honor Medical Society. Dr. Yawn completed her residency in Family Medicine at University of Minnesota, Minneapolis; two years later, she received her Masters in Family Medicine and Public Health, and her Master of Science in Clinical Research Design and Statistics from University of Michigan, Ann Arbor.
Since 1987, Dr. Yawn has published over 180 peer-reviewed articles, in addition to authoring and/or editing three books and producing a nationally syndicated radio health program. Her work appears in the Journal of the American Medical Association, Journal of Asthma, and Chest. Dr. Yawn has served as principal investigator for numerous clinical trials focused on physician-directed medication for asthma care, impact of spirometry testing in family medicine practices, and long-term trends in herpes zoster and varicella incidence.
Representative Publications:
Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members
Evidence gaps in the management of sickle cell disease: A summary of needed research
+myBinderRelated Content
-
Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease PatientsBackground: High utilization of emergenc...
-
Sarah Reeves, PhD, MPHDr. Reeves’ research is focused on imp...
-
Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chroni...Background: We undertook a large multisi...
-
Maria Grazia Roncarolo, MDMaria Grazia Roncarolo, MD is the co-dir...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
NYC Health + HospitalsNYC Health + Hospitals are the largest p...
-
Duke University Comprehensive Sickle Cell CenterHematologists at the Duke University Com...
